Elsevier,
International Encyclopedia of Human Geography (Second Edition), 2020, Pages 221-228
This chapter supports SDGs 3, 11, and 16 by exploring human geography approaches to issues faced by refugees and asylum seekers and analyzes processes shaping forced international migration and settlement.
Elsevier,
International Encyclopedia of Human Geography (Second Edition), 2020, Pages 121-128
This chapter supports SDGs 3, 11, and 16 by exploring the process of humanitarian mapping, the production of spatial data and cartographic products to improve situational awareness and decision-making around humanitarian issues from acute events such as natural disasters and public health emergencies to longer term events such as refugee crises and political unrest.
Elsevier,
Developments in Soil Science, Volume 36, 2019.
This book chapter advances SDGs 15 and 13 by discussing the impact of deforestation, rising temperatures, drought, fire and other ecological disturbances and the reduction of forest cover on much of the earth, compromising the ability of forests to supply important ecosystem services.
Fundamentals of Telemedicine and Telehealth, 2020, Pages 115-126
Discusses the universe of chronic disease and telehealth, from the patients’ perspective. The goal of SDG target 3.4.1 is to reduce the mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease.
Elsevier,
Bapon (SHM) Fakhruddin, Kate Boylan, Alec Wild, Rebekah Robertson, Chapter 12 - Assessing vulnerability and risk of climate change, Editor(s): Jana Sillmann, Sebastian Sippel, Simone Russo, Climate Extremes and Their Implications for Impact and Risk Assessment, Elsevier, 2020, Pages 217-241, 9780128148952
This book chapter advances SDG 13 by providing assessments of vulnerability and risk of extreme weather or climate events are essential in order to inform and implement appropriate prevention, adaptation, and mitigation strategies.
Elsevier,
Neuroprotection in Autism, Schizophrenia and Alzheimer's disease, Volume , 16 October 2019
This book chapter advances SDGs 3 and 17 by reviewing a new promising neuroprotective approach to treating AZ, Tau-based therapies including tau-kinase inhibitors to acetylation inhibitors, microtubule stabilizers, aggregation inhibitors, monoclonal anti-tau antibodies or active tau vaccines. Special emphasis has been placed on the most promising therapeutic agents that have reached clinical trials.
